Cell proliferation and apoptosis during prostatic tumor xenograft involution and regrowth after castration
Data up to Jan 2025
Total Citations Per Year
Abstract
References (27)
Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer.
1992 • 1,063 citations
Important Advances in Oncology
1991 • 768 citations
Activation of Programmed Cell Death in the Rat Ventral Prostate after Castration*
1988 • 730 citations
Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview
1992 • 600 citations
Detection of the apoptosis-suppressing oncoprotein bc1-2 in hormone-refractory human prostate cancers.
1993 • 597 citations
Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
1990 • 485 citations
Internucleosomal DNA Cleavage Should not be the Sole Criterion for Identifying Apoptosis
1992 • 462 citations
Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma.
1981 • 382 citations
Important advances in oncology 1994
1994 • 282 citations
Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration
1989 • 266 citations
Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle.
1992 • 245 citations
Apoptosis and Its Role in Human Disease
1994 • 232 citations
Serum prostate specific antigen levels in mice bearing human prostate LNCaP tumors are determined by tumor volume and endocrine and growth factors.
1992 • 228 citations
The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.
1975 • 218 citations
Cell death via apoptosis and its relationship to growth, development and differentiation of both tumour and normal cells.
1990 • 216 citations
Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation.
1993 • 201 citations
Activation of a Ca2+−Mg2+‐dependent endonuclease as an early event in castration‐induced prostatic cell death
1988 • 176 citations
Pathologic changes associated with androgen deprivation therapy for prostate cancer
1991 • 161 citations
Regulation of prostate growth
1991 • 159 citations
Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors.
1995 • 158 citations
Prostate Specific Antigen in Hormonally Treated Stage D2 Prostate Cancer: Is it always an Accurate Indicator of Disease Status?
1991 • 124 citations
Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer
1993 • 123 citations
Prostatic cell lineage markers: Emergence of BCL2+ cells of human prostate cancer xenograft LuCaP 23 following castration
1996 • 81 citations
Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
1994 • 54 citations
Prostatic tumor regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate.
1994 • 44 citations
Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated dunning R3327 prostatic adenocarcinoma
1993 • 41 citations
Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer
1994 • 40 citations
Cited By (0)
No citing papers found in database